Alrizomadlin Targets MDM2 in Salivary Cancers Trial
In a groundbreaking advancement in targeted cancer therapy, researchers have unveiled promising early clinical trial results for Alrizomadlin (APG-115), a...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advancement in targeted cancer therapy, researchers have unveiled promising early clinical trial results for Alrizomadlin (APG-115), a...
In a groundbreaking advance poised to redefine the landscape of immunotherapy, researchers have engineered a novel system that enables programmable...
In a groundbreaking revelation poised to rewrite immunological textbooks, researchers at Aarhus University have unveiled compelling new evidence detailing the...
Recent data from the Annenberg Public Policy Center (APPC) at the University of Pennsylvania reveals a concerning plateau in public...
In a groundbreaking advancement poised to transform oncology care, researchers at the Mayo Clinic have successfully demonstrated that intravenous chemotherapy...
In a groundbreaking advancement for pediatric surgical oncology, a recent study published in Scientific Reports has illuminated the transformative potential...
In the realm of colorectal malignancies, one rare yet highly aggressive variant demands greater scientific scrutiny: squamous cell carcinoma (SCC)...
In a groundbreaking development poised to transform breast cancer treatment for older women, researchers from the UPMC Hillman Cancer Center...
In a groundbreaking study set to redefine therapeutic strategies in lung adenocarcinoma, researchers have identified SERBP1 as a pivotal protein...
In recent years, extrachromosomal DNA (ecDNA) has surged to the forefront of cancer biology, emerging as a pivotal factor driving...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine